Related Experiment Video
Updated: May 17, 2025
Stereotactic Injection of MicroRNA-expressing Lentiviruses to the Mouse Hippocampus CA1 Region and Assessment of the Behavioral Outcome
Published on: June 10, 2013
Modulation of microRNA-502-3p significantly influences synaptic activity, dendritic spine density and mitochondrial
Abstract:
Synapse dysfunction is the root cause of Alzheimer's disease (AD). Uninterrupted and regulated synapse action is crucial to maintain healthy brain function. Our previous study discovered microRNA-502-3p (miR-502-3p), a synapse-specific miRNA, highly expressed at the AD synapses. Further, in vitro studies unveiled the biological relevance of miR-502-3p in modulating GABA receptor function, synaptic activity and mitochondrial morphology. Current study focuses to investigate the role of miR-502-3p in vivo using stereotaxic injection of miR-502-3p overexpression (OE) and suppression (sponge) lentivirus (LV) into the hippocampus of C57BL/6 wild-type (WT) mice. MiR-502-3p OE and sponge LV were characterized by transducing HT22 cells followed by QRT-PCR and miRNAScope analysis of miR-502-3p. MiR-502-3p OE LV showed a very high-fold upregulation and sponge LV showed significant reduction in miR-502-3p levels. MiR-502-3p OE and sponge LV were injected into three months old WT mice brain hippocampus. Overexpression and suppression effects of miR-502-3p were studied on synaptic proteins, synapse number, mitochondrial morphology and dendritic spine density at eight-weeks post-injection. Mice injected with miR-502-3p OE LV showed reduced levels of synaptic proteins, diminished synapse formation, defective mitochondrial morphology and reduced dendritic spine density relative to control LV treated mice. While mice treated with sponge LV showed elevated levels of synaptic proteins, augmented synapses, improved mitochondrial morphology and elongated dendrites and spine density. Our in vivo study unveiled translational abilities of miR-502-3p to restore synapse dysfunction in AD and other neurological disorders.
Insights
MicroRNA-502-3p (miR-502-3p) overexpression restored synapse function in mice, while suppression worsened it. This suggests miR-502-3p can treat Alzheimer's disease and other neurological disorders by fixing synapse dysfunction.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Synapse dysfunction is a key factor in Alzheimer's disease (AD) pathogenesis.
- MicroRNA-502-3p (miR-502-3p), a synapse-specific microRNA, is upregulated in AD synapses.
- Previous in vitro studies indicated miR-502-3p's role in synaptic and mitochondrial function.
Purpose of the Study:
- To investigate the in vivo effects of miR-502-3p overexpression and suppression on synaptic integrity.
- To determine the therapeutic potential of miR-502-3p in addressing synapse dysfunction in neurological disorders.
Main Methods:
- Stereotaxic injection of miR-502-3p overexpression (OE) and suppression (sponge) lentiviruses (LV) into the hippocampus of wild-type mice.
- Validation of lentivirus efficacy using QRT-PCR and miRNAScope analysis in HT22 cells.
- Assessment of synaptic proteins, synapse number, mitochondrial morphology, and dendritic spine density eight weeks post-injection.
Main Results:
- miR-502-3p OE mice exhibited reduced synaptic proteins, diminished synapse formation, defective mitochondria, and decreased dendritic spine density.
- miR-502-3p sponge mice showed elevated synaptic proteins, augmented synapses, improved mitochondrial morphology, and increased dendritic spine density.
- Control LV treated mice served as a baseline for comparison.
Conclusions:
- In vivo modulation of miR-502-3p levels directly impacts synaptic structure and function.
- Overexpression of miR-502-3p demonstrates a therapeutic potential for restoring synapse dysfunction.
- These findings highlight miR-502-3p as a promising target for treating Alzheimer's disease and other neurological disorders.
